Clover | Pandemic PACT Tracker

Key facts

Disease
COVID-19
Known Financial Commitments (USD)
$328,000,000
Funder
Coalition for Epidemic Preparedness Innovations (CEPI)
Principal Investigator
N/A
Research Location
China
Lead Research Institution
Clover Biopharma
Research Priority Alignment
N/A

Research Category
Vaccines research, development and implementation
Research Subcategory
Phase 1 clinical trial
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Clinical Trial, Phase I
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

Protein: Native-like Trimeric Subunit Vaccine Phase I safety and immunogenicity

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Functional Diversity of Serotonin Neurons in the Dorsal and Median Raphe Nuclei in Emotional Responses.

Early Fasting Serum Glucose or Weight Reduction With Tirzepatide and Metabolic Outcomes in People With Type 2 Diabetes: A Post Hoc Analysis of the SURPASS Trials.

Duality of Shehu transform with other well known transforms and application to fractional order differential equations.

A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity.

Effect of metformin in a novel experimental model of peripheral artery disease.

Water-directed pinning is key to tau prion formation.

Indoor climbing and well-being of young adults: Perspectives among indoor climbers.

DRug-coated Balloon for Endovascular treatment of sYmptOmatic intracraNial stenotic Disease (DR. BEYOND): the protocol of a multicentre randomised trial.

A core outcome set for acute otitis media (COS-AOM) for primary and community care studies.